Epstein-Barr virus in tumours

Histopathology

Volumn 29, Issue 4, 1996, Pages 297-315

  Anagnostopoulos, I ^a   Hummel, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Breast tumours; Burkitt's lymphoma; Epstein Barr virus; Gastric carcinoma; Hodgkin's disease; Lympho epithelioma like carcinomas; Nasopharyngeal carcinoma; non Hodgkin's lymphomas; Thymic tumours

Indexed keywords

BREAST CARCINOMA; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; STOMACH CARCINOMA; THYMOMA; VIRUS CARCINOGENESIS;

HUMAN HERPESVIRUS 4;

EID: 0029820663     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2559.1996.tb01414.x     Document Type: Review

References (182)

1. Epstein MA, Achong BG, Barr YM. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1964; i: 702-703.
2. Henle G, Henle W, Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA 1968; 59; 94-101.
3. Nonoyama M, Huang CH, Pagano JS, Klein G, Singh S. DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. USA 1973; 70; 3265-3268.
4. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 1970; 228; 1056-1058.
5. Okano M, Thiele GM, Davis JR. Grierson HL, Purtilo DT. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin. Microbiol. Rev. 1988; 1; 300-312.
6. Rocchi G, Felici A, Ragona G, Heinz A. Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N. Engl. J. Med. 1977; 296; 132-134.
7. Klein G, Klein E. Evolution of tumours and the impact of molecular oncology. Nature 1985; 315; 190-5.
8. Miller G. Epstein-Barr virus. In Fields BN, Knipe DM ed. Biology Pathogenesis Medical Aspects: Virology. 2nd edn. New York: Raven Press, 1990; 1921-1958.
9. Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc. Natl. Acad. Sci. USA 1984; 81; 4510-4514.
10. Fischer E, Delibrias C, Kazatchkine MD. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol. 1991; 146 (3); 865-869.
11. Sixbey JW, Nedrud JG, Raab Traub N, Hanes RA, Pagano JS. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 1984; 310; 1225-1230.
12. Liebowitz D, Kieff E. Epstein-Barr virus. In Roizman B. Whitley RJ, Lopez C ed. The Human Herpesviruses. New York: Raven Press, 1993: 107-172.
13. Bornkamm GW, Stein H, Lennert K, Ruggeberg F, Bartels H, zurHausen H. Attempts to demonstrate virus-specific sequences in human tumors. IV. EB viral DNA in European Burkitt lymphoma and immunoblastic lymphadenopathy with exceslsive plasmacytosis. Int. J. Cancer 1976; 17; 177-181.
14. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Halfull G, Hudson GS, Satchwell SC, Seguin C et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984; 310; 207-211.
15. Yates JL, Warren N, Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 1985; 313; 812-815.
16. Hudson GS, Bankier AT, Salchwell SC, Barrell BG. The short unique region of the B95-8 Epstein-Barr virus genome. Virology 1985; 147: 81-98.
17. Kieff E and Liebowitz D. Epstein-Barr virus and its replication. In Fields BN, Knipe DM ed. Virology. 2nd edn. New York: Raven Press, 1990; 1889-1920.
18. Woisetschlaeger M, Yandava CN, Furmanski LA, Strominger JL, Speck SH. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. Proc. Natl. Acad. Sci. USA 1990; 87; 1725-1729.
19. Rogers RP, Woisetschlaeger M, Speck SH. Alternative splicing dictates translational start in Epstein-Barr virus transcripts. EMBO J. 1990; 9; 2273-2277.
20. Laux G, Perricaudet M, Farrell PJ. A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. EMBO J. 1988; 7; 769-774.
21. Longnecker R, Kieff L. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J. Virol. 1990; 64; 2319-2326.
22. Chen MR, Middeldorp JM, Hayward SD. Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization sulidomains of novel structure. J. Virol. 1993; 67; 4875-4885.
23. Calender A, Cordier M, Billaud M. Lenoir GM. Modulation of cellular gene expression in B lymphoma cells following in vitro infection by Epstein-Barr virus (EBV). Int. J. Cancer 1990; 46; 658-663.
24. Ling PD, Rawlins DR, Hayward SD. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein. Proc. Natl. Acad. Sci. USA 1993; 90; 9237-9241.
25. Jilg W, Sieger E, Alliger P, Wolf H. Identification of type A and B isolates of Epstein-Barr virus by polymerase chain reaction. J. Virol. Methods 1990; 30; 319-322.
26. Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989; 2; 761-765.
27. Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. J. Virol 1995; 69; 3108-3116.
28. Mannick JB, Cohen JI, Birkenbach M, Marchini A, Kieff E. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyle transformation. J. Virol 1991; 65; 6826-6857.
29. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43; 831-840.
30. Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CT23. J. Virol. 1990; 64; 2309-2318.
31. Miller WE, Earp HS, Raab Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J. Virol. 1995; 69; 4390-4398.
32. Liebowitz D, Kopan R, Fuchs E, Sample J, Kieff E. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol. Cell Biol. 1987; 7; 2299-2308.
33. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80; 389-399.
34. Busson P, Edwards RH, Tursz T, Raab Traub N. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J. Gen. Virol. 1995; 76: 139-145.
35. Lerner MR, Andrews NC, Miller G, Steitz JA. Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupuserythematosus. Proc. Natl. Acad. Sci. USA 1981; 78; 805-809.
36. Glickman JN, Howe JG, Steitz JA. Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J. Virol 1988; 62; 902-911.
37. Toczyski DP, Steitz JA. EAP, a highly conserved cellular protein associated with Epstein-Barr virus small RNAs (EBERs). EMBO J. 1991; 10; 459-466.
38. Rowe M, Lear AL, Croom Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J. Virol. 1992; 66; 122-131.
39. Sample J, Brooks L, Sample C, Young L, Rowe M, Gregory C, Rickinson A, Kieff E. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl. Acad. Sci. USA 1991; 88; 6343-6347.
40. Miller G. The switch between latency and replication of Epstein-Barr virus. J. Infect. Dis. 1990; 161; 833-844.
41. Young LS, Lau R, Rowe M, Niedobitek G, Packham G, Shanahan F, Rowe DT, Greenspan D, Greenspan JS, Rickinson AB et al. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 1991; 65; 2868-2874.
42. Vieira P, de Waal Malefyt R, Dang MN, Johnson KE, Kastelein R, Florentino DF, deVries JE, Roncarolo MG, Mosmann TR, Moore KW. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRF1. Proc. Natl. Acad. Sci. USA 1991; 88; 1172-1176.
43. Oudejans JJ, van den Brule AJ, Jiwa NM, de Bruin PC, Ossenkoppele GJ, van der Valk P, Walboomers JM, Meijer CJ, BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytes. Blood 1995; 86; 1893-1902.
44. Andiman W, Gradoville L, Heston L, Neydorff R, Savage ME, Kitchingman G, Shedd D, Miller G. Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases. J. Infect. Dis. 1983; 148; 967-977.
45. Raab Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47; 883-889.
46. Katz BZ, Raab Traub N, Miller G. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J. Infect. Dis. 1989; 160; 589-598.
47. Gutierrez MI, Bhatia K, Magrath I. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies. Leuk. Res. 1993; 17; 285-289.
48. Gulley ML, Raphael M, Lutz CT, Ross DW, Raab Traub N. Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer 1992; 70; 185-191.
49. Weiss LM, Strickler JG, Warnke RA, Purtilo DT, Sklar J. Epstein-Barr viral DNA in tissues of Hodgkin's disease. Am. J. Pathol. 1987; 129; 86-91.
50. Herbst H, Niedobitek G, Kneba M, Hummel M, Finn T, Anagnostopoulos I, Bergholz M, Krieger G, Stein H. High incidence of Epslein-Barr virus genomes in Hodgkin's disease. Am. J. Pathol. 1990; 137; 13-18.
51. Wu TC, Mann RB, Epstein JI, MacMahon E, Lee WA, Charache P, Hayward SD, Kurman RJ, Hayward GS, Ambinder RF. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am. J. Pathol. 1991; 138; 1461-1469.
52. Anagnostopoulos I, Hummel M, Finn T, Tiemann M, Korbjuhn P, Dimmler C, Gatter K, Dallenbach F, Parwaresch MR, Stein H, Heterogeneous Epstein-Barr virus infection patterns in peripheral T-cell lymphoma of angioimmunoblastic lymphadenopathy type. Blood 1992; 80; 1804-1812.
53. Rowe M, Evans HS, Young LS, Hennessy K, Kieff E, Rickinson AB. Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells. J. Gen. Virol. 1987; 68; 1575-1586.
54. Young L, Alfieri C, Hennessy K, Evans H, O'Hara C, Anderson KC, Ritz J, Shapiro RS, Rickinson A, Kieff E et al. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease. N. Engl. J. Med. 1989; 321; 1080-1085.
55. Pallesen G, Sandvej K, Hamilton Dutoit SJ, Rowe M, Young LS. Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood 1991; 78; 1162-1165.
56. Burkitt DB. Sarcoma involving jaws in African children. Br. J. Surg. 1958; 46; 218-225.
57. Mitelman, F, Andersson-Anvet F, Brandt L, Catovsky D, Klein G, Manolov G, Manolova Y, Mark-Vendel E, Nilsson PG. Reciprocal; 8; 14 translocation in EBV-negative B-cell acute lymphocytic leukemia with Burkitt-type cells. Int. J. Cancer 1979; 24; 27-33.
58. Dalla Pavera R, Martinotti S, Gallo RC, Erikson J, Croce CM. Translocation and rearrangements of the c-myc oncogene locus in human undifferentiated B-cell lymphomas. Science 1983; 219: 963-967.
59. Marcu KB, Harris LJ, Stanton LW, Erikson J, Watt R, Croce CM. Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia. Proc. Natl. Acad. Sci. USA 1983; 80: 519-523.
60. Pagano JS, Huang CH, Levine P. Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma. N. Engl. J. Med. 1973; 289; 1395-1399.
61. Andersson M, Klein G, Teigler JL, Henle W. Association of Epstein-Barr viral genomes with American Burkitt lymphoma. Nature 1976; 260; 357-359.
62. Philip T, Lenoir GM, Bryon PA, Gerard-Marchant R, Souillet G, Philippe N, Freycon F, Brunat-Mentigny M. Burkilt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children. Br. J. Cancer 1982; 45 (5); 670-678.
63. Hamilton Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhoj P, Pedersen C. AIDS-related lymphoma. Histopathology, immunophenolype, and association with Epstein-Barr virus as demonstrated by ill situ nucleic acid hybridization. Am. J. Pathol. 1991; 138; 149-163.
64. Subar M, Neri A, Inghirami G, Knowles DM, Dalla Favera R. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 1988; 72; 667-671.
65. Magrath I. The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 1990; 55: 133-270.
66. Neri A, Barriga F, Knowles DM, Magrath IT, Dalla-Favera R. Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc. Natl. Acad. Sci. USA 1988; 85; 2748-2752.
67. Shiramizu B, Barriga F, Neequaye J, Jafri A, Dalla Favera R, Neri A, Guttierez M, Levine P, Magrath I. Patterns of chromosomal breakpoint locations in Burkitt's lymphoma: relevance to geography and Epstein-Barr virus association. Blood 1991; 77: 1516-1526.
68. Hummel M. Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types. J. Pathol. 1995; 175; 263-271.
69. Araujo I, Foss HD, Bittencourt A, Hummel M, Demel G, Mendonca N, Herbst H, Stein H. Burkitl's lymphoma in northeast Brazil: Frequent Epstein-Barr virus infection of tumor cells and expression of EBV encoded latent membrane protein in cases associated with Schistosoma mansoni infection. Blood 1996, in press.
70. Correa P, O'Conor GT. Epidemiologic patterns of Hodgkin's disease. Int. J. Cancer 1971; 8; 192-201.
71. Munoz N, Davidson RJ, Witthoff B, Ericsson JE, De-The G. Infectious mononucleosis and Hodgkin's disease. Int. J. Cancer 1978; 22; 10-13.
72. Gutensohn N. Cole P. Epidemiology of Hodgkin's disease. Semin. Oncol. 1980; 7; 92-102.
73. Mueller N, Evans A, Harris NL, Comstock GW, Jellum E, Magnus K, Orentreich N, Polk BF, Vogelman J. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N. Engl. J. Med. 1989; 320; 689-695.
74. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989; 74; 810-816.
75. Weiss LM, Movahed LA, Warnke RA, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N. Engl. J. Med. 1989; 320; 502-506.
76. Knecht H, Odermatt BF, Bachmann E, Teixeira S, Sahli R, Hayoz D, Heitz P, Bachmann F. Frequent detection of Epstein-Barr virus DNA by the polymerase chain reaction in lymph node biopsies from patients with Hodgkin's disease without genomic evidence of B- or T-cell clonality. Blood 1991; 78; 760-767.
77. Ohshima K, Kikuchi M, Eguchi F, Masuda Y, Sumiyoshi Y, Mohtai H, Takeshita M, Kimura N. Analysis of Epstein-Barr viral genomes in lymphoid malignancy using Southern blotting, polymerase chain reaction and in situ hybridization. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1990; 59; 383-390.
78. Shibata D, Hansmann ML, Weiss LM, Nathwani BN. Epstein-Barr virus infections and Hodgkin's disease: a study of fixed tissues using the polymerase chain reaction. Hum. Pathol. 1991; 22; 1262-1267.
79. Wright CF, Reid AH, Tsai MM, Ventre KM, Murari PJ, Frizzera G, O'Leary TJ. Detection of Epstein-Barr virus sequences in Hodgkin's disease by the polymerase chain reaction. Am. J. Pathol. 1991; 139; 393-398.
80. Masih A, Weisenburger D, Duggan M, Armitage J, Bashir R, Mitchell D, Wickert R, Purtilo DT. Epstein-Barr viral genome inlymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells. Am. J. Pathol. 1991; 139; 37-43.
81. Hummel M, Anagnostopoulos I, Dallenbach F, Korbjuhn P, Dimmler C, Stein H. EBV infection patterns in Hodgkin's disease and normal lymphoid tissue: expression and cellular localization of EBV gene products. Br. J. Haematol. 1992; 82; 689-694.
82. Grasser FA, Murray PG, Kremmer E, Klein K, Kemberger K, Feiden W, Reynolds G, Niedobitek G, Young LS, Mueller Lantzsch N. Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 1994; 84; 3792-3798.
83. Ambinder RF, Browning PJ, Lorenzana I, Leventhal BG, Cosenza H, Mann RB, MacMahon EM, Medina R, Cardona V, Grufferman S et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993; 81; 462-467.
84. Jarrett RF, Gallagher A, Jones DB, Alexander FE, Krajewski AS, Kelsey A, Adams J, Angus B, Gledhill S, Wright DH et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J. Clin. Pathol. 1991; 44; 844-848.
85. Khan G, Norton AJ, Slavin G. Epstein-Barr virus in Hodgkin disease. Relation to age and subtype. Cancer 1993; 71: 3124-3129.
86. Starzl TE, Penn I, Halgrimson CG. Immunosuppression and malignant neoplasms. N. Engl. J. Med. 1970; 283; 934.
87. Penn I. Cancer is a complication of severe immunosuppression. Surg. Gynecol. Obstet. 1986; 162; 603-610.
88. Calne RY, Rolles K, White DJ, Thiru S, Evans DB, McMaster P, Dunn DC, Craddock GN, Henderson RG, Aziz S, Lewis P. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 1979; 2; 1033-1036.
89. Cockburn I. Assessment of the risks of malignancy and lymphomas developing in patients using Sandimmune. Transplant Proc. 1987; 19: 1804-1807.
90. Kahan BD, Flechner SM, Lorher MI, Jensen C, Golden D, Van-Buren CT. Complications of cyclosporin therapy. World J. Surg. 1986; 10; 348-360.
91. Hanto DW, Gajl Peczalska KJ, Frizzera G, Arthur DC, Balfour HH, Jr., McClain K, Simmons RL, Najarian JS. Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring afler renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy. Ann. Surg. 1983; 198; 356-369.
92. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham JA, Makowka L, Ho M, Locker J. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am. J. Pathol. 1988; 133; 173-192.
93. Ferry JA, Jacobson JO, Conti D, Delmonico F, Harris NL. Lymphoproliferative disorders and hematologic malignancies following organ transplantation. Mol. Pathol. 1989; 2; 583-592.
94. Randhawa PS, Vousem SA, Paradis IL, Dauber JA, Griffith BP, Locker J. The clinical spectrum, pathology, and clonal analysis of Epstein-Barr virus-associated lymphoprolilerative disorders in heart-lung transplant recipients. Am. J. Clin. Pathol. 1989; 92: 177-185.
95. Zutter MM, Martin PJ, Sale GE, Shulman HM, Fisher L, Thomas ED, Durnam DM. Epslein-Farr virus lymphoproliferation after bone marrow transplantation. Blood 1988; 72: 520-529.
96. Shapiro RS, McClain K, Frizzera G, Gajl Peczalska KJ, Kersey JH, Blazar BR, Arthur DC, Patton DF, Greenberg JS, Burke B et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplanlalion. Blood 1988; 71; 1234-1243.
97. Hanto DW, Frizzera G, Purtilo DT, Sakamoto K, Sullivan JL, Saemundsen AK, Klein G, Simmons RL, Najarian JS. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res. 1981; 41: 4253-4261.
98. Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, Holahan KP, Lindquist LL. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 1981; 41; 4262-4279.
99. Nalesnik MA. Involvement of the gastrointestinal tract by Epstein-Barr virus - associated posttransplant lymphoproliferative disorders. Am. J. Surg. Pathol. 1990; 1; 92-100.
100. Purtilo DT, Klein G. Introduction to Epstein-Barr virus and lymphoproliferative diseases in immunodeficient individuals. Cancer Res. 1981; 41; 4209.
101. Saemundsen AK, Purtilo DT, Sakamoto K, Sullivan JL, Synnerholm AC, Hanto D, Simmons R, Anvret M, Collins R, Klein G. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/ DNA and viral DNA/DNA hybridization. Cancer Res. 1981; 41; 4237-4242.
102. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 1995; 85; 552-565.
103. Ross R, Dworsky R, Paganini-Hill A, Levine A, Mack T. Non-Hodgkin's lymphomas in never married men in Los Angeles. Br. J. Cancer. 1985; 52; 785-787.
104. Centers for Disease Control, and Prevention US. Revision of CDC/WHO case definition for acquired immunodeficiency syndrome (AIDS). Bull. Pan Am. Health Organ. 1988; 22; 195-201.
105. Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P, Ziegler J, Volberding PA. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261; 719-724.
106. Levine AM, Gill PS, Meyer PR, Burkes RL, Ross R, Dworsky RD, Krailo M, Parker JW, Lukes RJ, Rasheed S. Retrovirus and malignant lymphoma in homosexual men. JAMA 1985; 254; 1921-1925.
107. Knowles DM, Chamulak GA, Subar M, Burke JS, Dugan M, Wernz J, Slywotzky C, Pelicci G, Dalla-Favera R, Raphael B. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann. Intern. Med. 1988; 108; 744-755.
108. Lowenthal DA, Straus DJ, Campbell SW, Gold JW, Clarkson BD, Koziner B. AIDS-related lymphoid neoplasia. The Memorial Hospital experience. Cancer 1988; 61; 2325-37.
109. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N. Engl. J. Med. 1984; 311; 1471-1475.
110. Janier M, Katlama C, Flageul B, Valensi F. Moulonguet I, Sigaux F. Dompmartin D, Civatte J. The pseudo-Sezary syndrome with CD8 phenotype in a patient with the acquired immunodeficiency syndrome (AIDS). Ann. Intern. Med. 1989; 110; 738-740.
111. Crane GA, Variakojis D, Rosen ST, Sands AM, Roenigk HH. Cutaneous T-cell lymphoma in patients with human immunodeficiency virus infection. Arch. Dermatol. 1991; 127; 989-994.
112. Presant CA, Gala K, Wiseman C, Kennedy P, Blayney D, Sheibani K, Winberg CD, Rasheed S. Human immunodeficiency virus-associated T-cell lymphoblastic lymphoma in AIDS. Cancer. 1987; 60; 1459-1461.
113. Gonzalez-Clemente JM, Ribera JM, Campo E, Bosch X, Montserrat E, Grau JM. Ki-1 + anaplastic large-cell lymphoma of T-cell origin in an HIV-infected patient. AIDS 1991; 5; 751-5.
114. Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin lymphoma. Lancet 1991; 337; 805-809.
115. MacMahon EM, Glass JD, Hayward SD, Mann RB, Becker PS, Charache P, McArthur JC, Ambinder RF, Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 1991; 338; 969-973.
116. Meeker TC, Shiramizu B, Kaplan L, Herndier B, Sanchez H, Grimaldi JC, Baumgartner J, Rachlin J, Feigal E, Rosenblum M et al. Evidence for molecular subtypes of HIV-assodated lymphoma: division into peripheral monoclonal, polyclonal and central nervous system lymphoma. AIDS 1991; 5; 669-674.
117. Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT, Dalla Favera R. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood 1991; 77; 1092-1095.
118. Kalter SP, Riggs SA, Cabanillas F, Butler JJ, Hagemeister FB, Mansell PW, Newell GR, Velasquez WS, Salvador P, Barlogie B et al. Aggressive non-Hodgkin's lymphomas in immunocompromised homosexual males. Blood 1985; 66: 655-659.
119. Pelicci PG, Knowles DM, Arlin ZA, Wieczorek R, Luciw P, Dina D, Basilico C, Dalla-Favera R Multiple monoclonal B cell expansions and c-myc oncogene rearrangements in acquired immune deficiency syndrome-related lymphoproliferative disorders. Implications for lymphomagenesis. J. Exp. Med. 1986; 164; 2049-2060.
120. Shibata D, Weiss LM, Nathwani BN, Brynes RK, Levine AM. Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 1991; 77; 1527-1533.
121. Laurence J, Astrin SM. Human immunodeficiency virus induction of malignant transformation in human B lymphocytes. Proc. Natl. Acad. Sci. USA 1991; 88; 7635-7639.
122. Hamilton Dutoit SJ, Pallesen G. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am. J. Pathol 1992; 140; 1315-1325.
123. Jones JF, Shurin S, Abramowsky C, Tubbs RR, Sciolto CG, Wahl R, Sands J, Gottman D, Katz BZ, Sklar J. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N. Engl. J. Med. 1988; 318; 733-741.
124. Harabuchi Y, Yamanaka N, Kataura A, Imai S, Kinoshita T, Mizuno F, Osato T. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335; 128-130.
125. Weiss LM, Gaffey MJ, Chen YY, Frierson HF, Jr. Frequency of Epstein-Barr viral DNA in 'Western' sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am. J. Surg. Pathol. 1992; 16; 156-162.
126. Su IJ, Hsieh HC, Lin KH, Uen WC, Kao CL, Chen CJ, Cheng AL, Kadin ME, Chen JY. Aggressive peripheral T-cell lymphomas containing Epstein-Barr viral DNA: a clinicopathologic and molecular analysis. Blood 1991; 77; 799-808.
127. Zhou XG, Hamilton Dutoit SJ, Yan QH, Pallesen G. High frequency of Epstein-Barr virus in Chinese peripheral T-cell lymphoma. Histopathology 1994; 24; 115-122.
128. Ott G, Ott MM, Feller AC, Seidl S, Muller Hermelink HK. Prevalence of Epstein-Barr virus DNA in different T-cell lymphoma entities in a European population. Int. J. Cancer 1992; 51; 562-567.
129. de Bruin PC, Jiwa NM, van der Valk P, van Heerde P, Gordijn R, Ossenkoppele GJ, Walboomers JM, Meijer CJ. Detection of Epstein-Barr virus nucleic acid sequences and protein in nodal T-cell lymphomas: relation between latent membrane protein-1 positively and clinical course. Histopathology 1993; 23; 509-518.
130. Korbjuhn P, Anagnostopoulos I, Hummel M, Tiemann M, Dallenbach F, Parwaresch MR, Stein H. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B B cells in human immunodeficiency virus-negative European p peripheral pleomorphic T-cell lymphomas. Blood 1993; 82; 217-223.
131. Regaud C, Reverchon L. Sur un cas d'epitheloma epidermoide developpe dans les massif maxilaire superieur. Rev. Laryngol. Otol Rhinol. 1921; 42; 369-378.
132. Schminke A. Über lympha-epitheliale Geschwulste. Beitr Pathol. Anat Allg Pathol. 1921; 68; 161-170.
133. Liebowitz D, Kieff E. Epstein-Barr virus. In Roitman B, Whithey RJ, Lopez C ed. The human herpes viruses. New York: Raven Press. 1993; 107-172.
134. Huang DP, Ho HC, Henle W, Henle G, Saw D, Lui M. Presence of EBNA in nasopharyngeal carcinoma and control, patient tissues related to EBV serology. Int. J. Cancer 1978; 22; 266-274.
135. Henle G, Henle W, Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Im. J. Cancer 1976; 17; 1-7.
136. Sam CK, Brooks LA, Niedobitek G, Young LS, Prasa L, Rickinson AB. Analysis of Epstein-Barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. Int J. Cancer 1993; 53; 957-962.
137. Sato H, Rajadurai P, Busson P, Young L, Rickinson A, Tursz T, Raab Traub N. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment. DIJhet, in a nasopharyngeal carcinoma. J. Virol. 1990; 64; 4948-4956.
138. Gilligan KJ, Rajadurai P, Lin JC, Bussor P, Abdel Hamid M, Prasad U, Tursz T, Raab Traub N. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J. Virol. 1991; 65; 6252-6259.
139. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J. Virol. 1992; 66; 2689-2697.
140. Busson P, McCoy R, Sadler R, Gilligan K, Tursz T, Raab Traub N. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J. Virol. 1992; 66; 3257-3262.
141. Martel Renoir D, Grunewald V, Touitou R, Schwaab G, Joab I, Qualitative analysis of the expression of Epstein-Barr virus lytic genes in nasopharyngeal carcinoma biopsies. J. Gen. Virol. 1995; 76; 1401-1408.
142. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 1995; 333; 693-698.
143. Shibata D, Tokunaga M, Lemura Y, Sato E, Tanaka S, Weiss IAI. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am. J. Pathol. 1991; 139; 469-474.
144. Oda K, Tamaru J, Takenouchi T, Mikata A, Nunomura M, Saitoh N, Sarashina H, Nakajima N. Association of Epstein-Barr v virus with gastric carcinoma with lymphoid stroma. Am. J. Pathol. 1993; 143; 1063-1071.
145. Yuen ST, Chung LP, Leung SYm Luk IS, Chan SY, Ho J. In situ d defection of Epstein-Barr virus in gastric and colorectal adenocarcinomas. Am J. Surg. Pathol. 1994; 18; 1158-1163.
146. Niedobitel G, Herbst H, Young LS, Rowe M, Dienemann D, Germer C, Stein H. Epstein-Barr virus and carcinomas. Expression of the viral genome in an undifferentiated gastric carcinoma. Diagn. Mol. Pathol. 1992; 1; 103-108.
147. Fukayama M, Hayashi Y, Iwasaki Y, Chong J, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab. Invest. 1994; 71; 73-81.
148. Chan JK, Yip TL, Tsang WY, Poon YT, Wong CS, Ma VW. Specific association of Epstein-Barr virus with lymphoepithelial carrcinoma among tumors and tumorlike lesions of the salivary gland. Arch. Pathol. Lab. Med. 1994; 118; 994-997.
149. Hamilton Dutoit SJ, Therkildsen MH, Neilsen NH, Jensen H, Hansen JP, Pallesen G. Undifferentiated carcinoma of the salivary gland in Greenlandic Eskimos: demonstration of E Epstein-Barr virus DNA by in situ nucleic acid hydridization. Hum. Pathol. 1991; 22; 811-815.
150. Huang DP, Ng HKm Ho YH, Chan KM. Epstein-Barr virus (EBV)-a associated undifferentiated carcinoma of the parotid gland. Histopathology 1988; 13; 509-517.
151. Krishnamurthy S, Lanier AP, Dohan P, Lanier JE, Henle W. Salivary gland cancer in Alaskan natives 1966-1980. Hum. Pathol. 1987; 18; 986-996.
152. Lanier AP, Bornkamm GW, Henle W, Henle G, Bender TR, Talbot ML, Dohan PH. Association of Epstein-Barr virus with n nasopharyngeal carcinoma in Alaskan native patients serum antibodies and tissue EBNA and DNA. Int J. Cancer. 1981; 28; 301-305.
153. Saemundsen AK, Albeck H, Hansen JP, Nielsen NH, Anvrei M, Henle W, Henle G, Thomsen KA, Kristensen HK, Klein G. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimos. Br. J. Cancer 1982; 46; 721-728.
154. Butler AE, Colby TV, Weiss L, Lombard C. Lymphoepithelioma-like carcinoma of the lung. Am. J. Surg. Pathol.1989; 13; 632-639.
155. GAll AA, Unger ER, Koss MN, Yen TS. Detection of Epstein-Barr virus in lymphoepithelioma-like carcinoma of the lung. Med. Pathol. 1994; 4; 264-268.
156. Miller B, Montgomery C, Watne AL, Johnson D, Bailey T, Kowalski R. Lymphoepithelioma-like carcinoma of the lung. J. Surg. Oncol. 1994; 48; 62-68.
157. Pittaluga S, Wong MP, Chung LP, Loke SL. Clonal Epstein-Barr virus in lymphoepithelioma-like carcinoma of the lung. Am. J. Surg. Pathol. 1993; 17; 678-682.
158. Borish B, Kirchner T, Marx A, Muller Hermelink HK. Absence of the Epstein-Barr virus genome in the normal thymus, thymic epithelial tumors thymic lymphoid hyperplasia in a European population. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 1990; 59; 359-365.
159. Dimery TW, Less JS, Blick M, Pearson G, Spitzer G, Hong WK. Association of the Epstein-Barr virus with lymphoepithelioma of the thymus. Cancer 1988; 61; 2475-2480.
160. Inghirami G, Chilosi M, Knowles DM. Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction. Am. J. Pathol. 1990; 136; 1429-1436.
161. Leyvraz S, Henlo W, Chahinian AP, Perlmann C, Klein G, Gordon RE,
162. Matsuno Y, Mukai K, Uhara H, Akao I, Furuya S, Sato Y, Hirohashi S, Shimosato Y. Detection of Epstein-Barr virus DNA in a Japanese case of lymphoepithelioma-like thymic carcinoma. Jpn J. Cancer Res. 1992; 83; 127-130.
163. MeGuire LJ, Huang DP, Teoh R, Arnold M, Wong K, Lee JC. Epstein-Barr virus genome in thymoma and thymic lymphoid hyperplasia. Am. J. Pathol. 1988; 131; 385-390.
164. Niedobitek G, Hansmann ML, Herbst H, Young LS, Dienemann D, Hartmann CA, Finn T, Pitteroff S, Welt A, Anagnostopoulos I et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J. Pathol. 1991; 165; 17-24.
165. Wu TC, Kuo TT. Study of Epstein-Barr virus early RNA 1 (EBLR1) expression by in situ hyhridization in thymic epithelial tumors of Chinese patients in Taiwan. Hum. Pathol. 1993; 24; 235-238.
166. Carr KA, Bulengo Ransby SM, Weiss LM, Nickoloff BJ, Bulengo-Ransby SM. Lymphoepitheliomalike carcinoma of the skin. A case report with immunophenotypic analysis and in situ hybridization for Epstein-Barr viral genome. Am. J. Surg. Pathol. 1992; 16; 909-913.
167. Wick MR, Swanson PE, LeBoit PE, Strickler JG, Cooper PH. Lymphoepithelioma-like carcinoma of the skin with adnexal differentiation. J. Cutan. Pathol. 1991; 18; 93-102.
168. Weiss LM, Movahed LA, Butler AE, Swanson SA, Frierson HF, Jr., Cooper PH, Colby TV, Mills SE. Analysis of lymphoepithelioma and lymphoepithelioma-like carcinomas for Epstein-Barr viral genomes by in situ hybridization. Am. J. Surg. Pathol. 1989; 13; 625-631.
169. Dinney CP, Ro JY, Babaian RJ, Johnson DE. Lymphoepithelioma of the bladder: a clinicopathological study of 3 cases. J. Urol. 1993; 149; 840-841.
170. Zukerberg LR, Harris NL, Young RH. Carcinomas of the urinary bladder simulating malignant lymphoma. A report of five cases. Am. J. Surg. Pathol. 1991; 15; 569-76.
171. Brichacek B, Hirsch I, Sibl O. Vilikusova E, Vonka V. Presence of Epstein Barr virus DNA in carcinomas of the palatine tonsil. J. Natl. Cancer Inst. 1984; 72; 809-815.
172. Mori M, Watanabe M, Tanaka S, Mimori K, Kuwano H, Sugimachi K. Epstein-Barr virus-associated carcinomas of the esophagus and stomach. Arch. Pathol. Lab. Med. 1994; 118; 998-1001.
173. Shibata D, Weiss IAI. Epstein-Barr virus-associated gastric adenocarcinoma. Am. J. Pathol. 1992; 140; 769-774.
174. Oda K, Tamaru J, Takenouchi T, Mikata A, Nunomura M, Saitoh N, Sarashina H, Nakajima N. Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am. J. Pathol. 1993; 143; 1063-1071.
175. Leoncini L, Vindigni C, Megha T, Funto I, Pacenti L, Musaro M, Renieri A, Seri M, Anagnostopoulos J, Tosi P. Epstein-Barr virus and gastric cancer: data and unanswered questions. Int. J. Cancer 1993; 53; 898-901.
176. Tokunaga M, Land CE, Uemura Y, Tokudome T, Tanaka S, Sato E. Epstein-Barr virus in gastric carcinoma. Am. J. Pathol. 1993; 143; 1250-1254.
177. Rowlands DC, Ho M, Maugham DC, Reynolds G, Herbst H, Hallissey MT, Fielding JW, Newbold KM. Jones EL, Young LS et al. Epstein-Barr virus and carcinomas: rare association of the virus with gastric adenocarcinomas. Br. J. Cancer 1993; 68; 1014-1019.
178. Ott G, Kirchner T, Muller-Hermelink HK. Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology 1994; 25; 323-329.
179. Levine PH, Stemmermann G, Lennette ET, Hildesheim A, Shibata D, Nomura A. Elevated antibody titers to Epstein-Barr virus prior to the diagnosis of Epstein-Barr-virus-associated gastric adenocarcinoma. Int. J. Cancer 1995; 60; 642-644.
180. Fujii T, Kawai T, Saito K, Fukushima K, Hasegawa T, Tokunaga M, Yokoyama T. EBER-1 expression in thymic carcinoma. Acta Pathol. Jpn 1993; 43; 107-110.
181. Weide LG, Ulbright TM, Loehrer PJ Sr, Williams SD. Thymic carcinoma. A distinct clinical entity responsive to chemotherapy. Cancer 1993; 71; 1219-1223.
182. Chang KK, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn. Mol. Pathol. 1992; 1; 246-255.